Evidence map›Paper›PMID 35623914›Full record

ArticleNeuro-Chirurgie2022

Financial fallout from the COVID-19 pandemic:Report from a high-volume academic neurosurgery.

G Loganadane, S Senova, P Duportail, K Debbi, M A Cherif, S Ghith, S Tazi, A Marniche, G Gouello, T Idreceanu and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuro-Chirurgie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

G LoganadaneDepartment of Radiation Oncology, AP-HP, Inserm Unit 955 Team 21, University of Paris-Est Creteil (UPEC), Créteil, France.
S SenovaDepartment of Neurosurgery, DMU Care, FHU adapt, Mondor Institute of Biomedical Research, Translational psychiatry, AP-HP, Inserm Unit 955 Team 15, University of Paris-Est Creteil (UPEC), Créteil, France.
P DuportailDepartment of Medical Informatics, AP-HP, CHU Henri Mondor, University of Paris-Est Creteil (UPEC), Créteil, France.
K DebbiDepartment of Radiation Oncology, AP-HP, Inserm Unit 955 Team 21, University of Paris-Est Creteil (UPEC), Créteil, France.
M A CherifDepartment of Radiation Oncology, AP-HP, Inserm Unit 955 Team 21, University of Paris-Est Creteil (UPEC), Créteil, France.
S GhithDepartment of Radiation Oncology, AP-HP, Inserm Unit 955 Team 21, University of Paris-Est Creteil (UPEC), Créteil, France.
S TaziDepartment of Neurosurgery, DMU Care, FHU adapt, Mondor Institute of Biomedical Research, Translational psychiatry, AP-HP, Inserm Unit 955 Team 15, University of Paris-Est Creteil (UPEC), Créteil, France.
A MarnicheDepartment of Neurosurgery, DMU Care, FHU adapt, Mondor Institute of Biomedical Research, Translational psychiatry, AP-HP, Inserm Unit 955 Team 15, University of Paris-Est Creteil (UPEC), Créteil, France.
G GouelloDepartment of Neurosurgery, DMU Care, FHU adapt, Mondor Institute of Biomedical Research, Translational psychiatry, AP-HP, Inserm Unit 955 Team 15, University of Paris-Est Creteil (UPEC), Créteil, France.
T IdreceanuDepartment of Neurosurgery, DMU Care, FHU adapt, Mondor Institute of Biomedical Research, Translational psychiatry, AP-HP, Inserm Unit 955 Team 15, University of Paris-Est Creteil (UPEC), Créteil, France.
P KauvDepartment of Neuroradiology, AP-HP, CHU Henri Mondor, University of Paris-Est, Créteil (UPEC), Créteil, France.
P VarletDepartment of Neuropathology, Sainte-Anne Hospital, Paris, France.
Y BelkacemiDepartment of Radiation Oncology, AP-HP, Inserm Unit 955 Team 21, University of Paris-Est Creteil (UPEC), Créteil, France.
S PalfiDepartment of Neurosurgery, DMU Care, FHU adapt, Mondor Institute of Biomedical Research, Translational psychiatry, AP-HP, Inserm Unit 955 Team 15, University of Paris-Est Creteil (UPEC), Créteil, France. Electronic address: stephane.palfi@aphp.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe global healthcare system has been overwhelmed by the Coronavirus disease-2019 (COVID-19). In order to mitigate the risk of spread of the virus, most elective surgical procedures have been cancelled especially during the lockdown periods. The purpose of this study was to assess the financial impact of the COVID outbreak due to the supposed reduced workload from our neurosurgery department in 2020.

methodsNumber of neurosurgical procedures (NSP) within the Department of Neurosurgery and their associated estimated income were retrospectively reviewed globally and month wise from administrative records of billing in 2020 and 2019 based on the Diagnosis related group (DRG) and severity of illness (4 levels).

resultsOverall, 824 and 818 inpatient surgical procedures were performed in 2019 and 2020 respectively. The total estimate revenue generated from inpatient surgeries was moderately decreased (3%): 9 498 226.41 euros in 2020 versus 9 817 361.65 euros in 2019 without significant difference across DRG (P=0.96) and severity of illness.

conclusionsOur data suggests a moderate negative impact of the COVID-19 pandemic had on neurosurgical and financial activity. However, a more in-depth medico-economic analysis need to be performed to assess the real financial impact.

Indexed as

COVID-19NeurosurgeryCommunicable Disease ControlHumansNeurosurgical ProceduresPandemicsRetrospective StudiesCovid 19 pandemicIncomeNeurosurgical procedures

Identifiers

PMID35623914
PMCPMC9127702

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.